Clorox said its net sales for fiscal 2024 fell 4% to $7,093 from $7,389 a year earlier, citing lower shipments resulting from the impacts of the cyberattack and higher pricing as factors.

1. 01

   Clorox said its net sales for fiscal 2024 fell 4% to $7,093 from $7,389 a year earlier, citing lower shipments resulting from the impacts of the cyberattack and higher pricing as factors.

2. 02

   The company said its gross margin in fiscal 2024 rose 360 basis points to 43.0% from 39.4%, citing the benefit of price increases and cost savings as drivers, and said unfavorable foreign exchange rates partially offset the gain.

3. 03

   Clorox said its diluted net earnings per share for fiscal 2024 rose to $2.25 from $1.20 a year earlier, an increase of $1.05 (about 88%), and attributed the gain mainly to the prior-year noncash impairment charges on assets held by the Better Health VMS business and to pricing and cost savings in the current year.

4. 04

   Clorox said net cash provided by operations for fiscal 2024 was $695, compared with $1,158 a year earlier, and free cash flow was $483, or 6.8% of net sales, compared with $930, or 12.6%, a year earlier.

Key figures

Fiscal year ended June 30, 2024

Revenue

$7.1B

Net income

$280M

EPS

$2.25

Gross profit

$3.0B

Operating cash flow

$695M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.